ACGN's logo.
Ticker Symbol: ACGN

Aceragen Inc

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0000861838

Company Profile

idera pharmaceuticals is a clinical stage biotechnology company with expertise in discovering, developing and commercializing novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases. idera is focused on harnessing the potential of our proprietary technology to treat genetically defined forms of b-cell lymphomas and rare autoimmune diseases.

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 505 Eagleview Blvd Ste 212
CEO: Vincent Milano
Tags: N/A


Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change: - ( 0.00%)
Days Range: $0.38 - $0.38
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.00%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 8423504


Market Cap: 320.1M
PE Ratio: -0.14
EPS (TTM): -2.67


Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A